Last reviewed · How we verify
NCT07353736
Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
trial in Cerebral Arteriovenous Malformation in 630 participants. Not yet recruiting.
30 November 2030
Quick facts
| Lead sponsor | Duan Chuanzhi |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 630 |
| Start date | 1 February 2026 |
| Primary completion | 30 November 2030 |
| Estimated completion | 30 December 2030 |
| Sites | 1 location across China |
Conditions studied
- Cerebral Arteriovenous Malformation — all drugs for Cerebral Arteriovenous Malformation →
- Intracranial Arterial Diseases — all drugs for Intracranial Arterial Diseases →
- Intra Cerebral Hemorrhage — all drugs for Intra Cerebral Hemorrhage →
- Intracranial Aneurysm — all drugs for Intracranial Aneurysm →
Sponsor
Duan Chuanzhi — full company profile →
Who can join
Eligibility, any sex, with Cerebral Arteriovenous Malformation or Intracranial Arterial Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07353736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Duan Chuanzhi trials
Trials by the same sponsor.
- NCT07353749 — Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms · Phase 4 · not yet recruiting
- NCT06308952 — Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07353736 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duan Chuanzhi
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07353736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing